Phenominer Database Results (7 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Record ID Study ID
DA/Bkl percentage of study population developing experimental arthritis during a period of time type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Joe B, et al., Immunogenetics 2000 Sep;51(11):930-44. joint integrity trait male 63 days-126 days 15 100.0 % in vivo visual assessment 3024000.0 0 70146 1299
DA/Bkl percentage of study population developing experimental arthritis during a period of time type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Joe B, et al., Immunogenetics 2000 Sep;51(11):930-44. joint integrity trait female 63 days-126 days 14 100.0 % in vivo visual assessment 3024000.0 0 70147 1299
DA/Bkl percentage of study population developing experimental arthritis during a period of time Freund's incomplete adjuvant (0.1 ml) Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11 joint integrity trait male 77 days-105 days 10 50.0 % in vivo visual assessment 0.0 0 69551 1158
DA/Bkl percentage of study population developing experimental arthritis during a period of time 0.9% sodium chloride solution (0.1 ml) Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11 joint integrity trait male 77 days-105 days 10 0.0 % in vivo visual assessment 0.0 0 97070 1158
DA/Bkl percentage of study population developing experimental arthritis during a period of time 0.9% sodium chloride solution (0.1 ml) Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11 joint integrity trait male 77 days-105 days 12 0.0 % in vivo visual assessment 0.0 0 97071 1158
DA/Bkl percentage of study population developing experimental arthritis during a period of time Freund's incomplete adjuvant (0.1 ml) Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11 joint integrity trait male 77 days-105 days 12 83.3 % in vivo visual assessment 0.0 0 69552 1158
DA/Bkl percentage of study population developing experimental arthritis during a period of time type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 joint integrity trait both 66 days-126 days 105 100.0 % in vivo visual assessment 0.0 immunized 10 days variable 69959 850